NRD
Nebula Research & Development’s Regeneron Pharmaceuticals REGN Stock Holding History
| Quarter | Market Value | Status | Shares |
Shares Change % | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | $2.4M | Buy |
4,575
+892
| +24% | +$468K | 0.2% | 151 |
|
|
2025
Q1 | $2.34M | Buy |
3,683
+2,080
| +130% | +$1.32M | 0.22% | 125 |
|
|
2024
Q4 | $1.14M | Sell |
1,603
-1,957
| -55% | -$1.39M | 0.13% | 252 |
|
|
2024
Q3 | $3.74M | Buy |
+3,560
| New | +$3.74M | 0.45% | 11 |
|
|
2024
Q2 | – | Sell |
-469
| Closed | -$451K | – | 1008 |
|
|
2024
Q1 | $451K | Sell |
469
-1,079
| -70% | -$1.04M | 0.1% | 391 |
|
|
2023
Q4 | $1.36M | Buy |
+1,548
| New | +$1.36M | 0.41% | 37 |
|